CONVERGE IDE Study VAL-1200D

• Research type

  Research Study

• Full title

  Convergence of Epicardial and Endocardial RF Ablation for The Treatment of Symptomatic Persistent AF

• IRAS ID

  227790

• Contact name

  Jaswinder Gill

• Contact email

  jaswinder.gill@gstt.nhs.uk

• Sponsor organisation

  AtriCure, Inc.

• Clinicaltrials.gov Identifier

  NCT01984346

• Duration of Study in the UK

  5 years, 7 months, 22 days

• Research summary

  This is a multi-center, open label, randomized pivotal study evaluating the safety and efficacy of the EPi-Sense-AF Guided Coagulation System for the treatment of persistent AF patients, refractory or intolerant to at least one Class I and/or Ill Anti Arrhythmic Drug (AAD).

• REC name

  London - Stanmore Research Ethics Committee

• REC reference

  17/LO/1101

• Date of REC Opinion

  10 Aug 2017

• REC opinion

  Further Information Favourable Opinion